Actemra/RoActemra, arthritis drug from Roche fails to meet primary endpoint of COVID-19 trial Read more
Pharma industry thinks high-risk groups should get priority for COVID-19 vaccine: GlobalData Poll Read more
Health ministry decides against including Itolizumab in clinical management protocols for COVID-19 Read more
US DOJ permits six drug makers to share info about COVID-19 MAb treatments to expedite production Read more